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1. Introduction
  Population control remains one of humankind’s 
greatest challenges in the 21st century. The population 
burden continues to tax our environment and contribute 
to morbidity and mortality globally. It is the hope of 
researchers in the field of male contraceptive development 
that approaches to blocking sperm production and function 
will bring the dream of the “male pill” to fruition and 
significantly impact the health and future of the planet[1]. 
The folklore information and ancient literature about the 
plants and herbs can help the antifertility program[2]. 
Research on Indian plants with male antifertility activity 
has been exhaustively reviewed recently[2-4]. However, the 
search for effective, safe and orally active plant products 
are yet to be needed for fertility regulation.
  Enicostemma axillare (Lam.) Raynal. (Syn. Enicostema 
littorale Blume) (E. axillare), belongs to the family 
Gentianaceae, (Family Gentianaceae) is a perennial herb 
found throughout India and common in coastal areas[5]. The 
plant is used in folk medicine to treat diabetes mellitus, 
rheumatisum, abdominal ulcers, hernia, swelling, itching 
and insect poisoning[6]. In recent years, this plant is 
reported to possess anti inflammatory[7], hypolipidemic 
and antioxidant antidiabetic[8], hepatoprotective[9], 
antinociceptive[10] and antimicrobial properties[11]. 
Objective: To evaluate the possible antifertility activity of Enicostemma axillare (E. axillare) 
leaves and Urena lobata (U. lobata) root in adult male Wistar albino rats. Methods: Six groups of 
rats were treated with ethanolic (70%v/v) extracts of E. axillare (375 and 750 mg/kg body weight) 
and U. lobata root (300 and 600 mg/kg body weight) once daily for 55 days. Control groups received 
the distilled water and vehicle. All the treated rats had corresponding recovery groups. At the end 
of each treatment periods, animals were killed and organ weights, sperm characteristics, testicular 
and epididymal biochemicals as well as testicular enzymes were assessed. Results: The E. 
axillare and U. lobata at tested doses did not decrease body weight, whereas the weight of testes, 
epididymides and seminal vesicles were significantly (P<0.01) reduced. Significantly (P<0.01) 
more reductions in the sperm motility, viability and counts, epididymal and testicular protein 
contents were noted in the rats treated with higher dose of both the plants.  Both the plants at the 
higher dose caused a marked increase (P<0.01) in sperm morphological abnormalities, testicular 
cholesterol and ascorbic acid contents were remarkably increased (P<0.01), while, the activities 
of testicular glucose-6-phosphate dehydrogenase (G-6-PDH) and ∆5-3毬-hydroxy steroid 
dehydrogenase (∆5-3毬-HSD) were significantly reduced (P<0.01). However, reversal of these 
changes occurred after 55 days of treatment withdrawal. Conclusions: This study suggests that 
the E. axillare leaves and U. lobata root reversibly inhibited spermatogenesis and steroidogenesis 
indicating reversible antifertility activity which could partially support the traditional of these 
plants as male contraceptives.
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  Urena lobata Linn (Family: Malvaceae) (U. lobata) is an 
annual shrub of 60-250 cm or more height and distributed 
in hotter parts of India[12]. In traditional medicine, this plant 
is being used to cure diarrhea, colic, skin diseases, boils, 
pneumonia, rheumatism, cough, and diabetes in India, 
Indonesia, Malaysia, Philippines, Cuba, and Nepal[13-16].
Roots have been reported to possess a broad spectrum 
of antibacterial activity[13,17]. In recent years, the root of 
this plant has been shown to have anti-diabetic[18] and 
immunomodulatory[19] effects. Imperatorin, a furocoumarin 
was isolated from the roots[20].
  In addition, the information collected from local traditional 
practioners in different places of southern India revealed 
that the E. axillare leaves and U. lobata root are being 
taken orally to develop sterility in man. However, the proper 
scientific researches on antifertility effects these two plants 
have not been carried out before to verify the traditional 
claims. Based on this background, therefore, the present 
study was undertaken to evaluate the possible antifertility 
activity at various doses of 70% ethanol extract E. axillare 
leaves and U. lobata root in male albino rats.
2. Materials and methods
2.1. Plant materials and preparation of extracts 
  The leaves of E. axillare and roots of U. lobata were 
collected from Sillathur village of Thanjavur District, 
Tamilnadu, India, in the year of 2006. The plants specimen 
was authenticated by Dr. P. Jayaraman, M.Sc., Ph.D, Plant 
Anatomy Research Centre (PARC), Chennai Tamil Nadu, 
India. A voucher specimen (E. axillare-PARC/2006/378 
and U. lobata -PARC/2006/383) have been deposited in the 
herbarium of the same department. The pars of the plants 
were separately dried in shade, pulverized by a mechanical 
grinder and passed through 40-mesh sieve and stored in 
airtight container for further use.
  The powdered dry parts of the selected plants about 500 g
were individually extracted successively with 70% v/v 
ethanol at 68 曟 in Sohxlet apparatus. The extracts were 
collected in 5 L individual conical flasks, filtered, and the 
solvent was evaporated to dryness under reduced pressure 
in an Eyela Rotary Evaporator (Japan) at 40-45 曟 and 
were stored in a vacuum desiccators. The yields (% w/w) of 
the prepared extracts were found to be 9.6% and 12.4% for
E. axillare leaves and U. lobata root extracts, respectively, 
with respect to dried powder. The extracts were dissolved 
individually in 1% Tween80 solution and were used for 
experimental purpose.
2.2. Animals used
  Adult Wistar strain male and female albino rats, Rattus 
norvegicus (90 days old), weighing 150-200 g, procured 
from Animal house, were housed in groups of five per cage 
made of polypropylene (8”×12”×8”) with metal grill tops. 
The animals were maintained with standard pellet feed 
(Sai Durga Feeds and Foods, Bangalore, India) and water 
ad libitum. All experimental procedures described were 
reviewed and approved by the University Animal Ethical 
Committee[21].
2.3. Acute oral toxicity study 
  The ethanolic extracts of E. axillare leaves and U. lobata 
root were administered as a single dose using a gastric 
intubation tube after fasting for 3 to 4 h. The substance 
is tested using a stepwise procedure, each step using 
three animals of a single sex (females). Since there was no 
information on the substance to be tested (i.e. extracts), 
starting dose was 2 000 mg/kg body weight up to 5 000 mg/kg
body weight. Animals were observed initially after dosing 
at least once during the first 30 min, periodically during the 
first 24 h. In all cases death was observed within first 24 h.
Attention was also given to observations of tremors and 
convulsions[22].
2.4. Design of experiment 
  Sixty healthy male albino rats were selected and divided 
into six groups containing ten rats each and treated as 
follows: 
  Group-1 received distilled water (10 mL/kg. b.w) as normal 
control; Group-2 received 1% Tween 80 dissolved in distilled 
water (10 mL/kg b.w) as vehicle control; Groups-3 and 4 
received ethanolic extract of E. axillare leaves at the doses 
of 375 and 750 mg/kg body weight, respectively, suspended 
in 1% Tween 80; Groups-5 and 6 received and U. lobata 
root at the doses of 250 and 500 mg/kg b.w respectively, 
suspended in 1% Tween 80.
  The vehicles and plant drugs were administered intragastric 
(i.g.) route on consecutive days for 55 days. At the end of 
the experimental period, five animals from both control 
and experimental groups were given anesthesia under 
mild sodium pentobarbital 24 h after the last dose and 18 h 
after fasting. Blood was also obtained by cardiac puncture 
from these animals for the analysis of hematological 
profiles. The testis, cauda epididymal ducts and seminal 
vesicles were dissected out, trimmed off from adherent fats 
and weighed and recorded to the nearest milligram on a 
digital balance. Sperm from cauda epididymal ducts were 
released in phosphate buffer solution (pH-9.0) media and 
used for spermatological studies. The testes were used for 
biochemical estimation. The remaining five rats from groups 
(3-6) were left for recovery studies over a period of next 
55 days (from 56th day to 110th day). All spermatological 
parameters were repeated in order to ascertain the nature of 
action of extract, i.e. reversible or irreversible.
  The body weights of the animals were recorded, prior 
to and after treatment and recovery. Testis, epididymis, 
seminal vesicles and ventral prostate gland were weighted to 
the nearest milligrams.
2.5. Spermatological studies
  The cauda epididymal duct on one side was exposed and 
incised. The connective tissue capsule around the cauda 
epididymidis was teased out and the epididymal duct 
was uncoiled. The semen that oozed into the cavity block 
was quickly sucked into a capillary tube up to 0.05 毺L 
mark and transferred to an Eppendorf tube. It was diluted
200 (0.05 毺L of sperm with 99.95 毺L of PBS) times in 
physiological saline. After thorough mixing, the sperm 
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suspension was used for analysis of motility[23].
  A drop of dilute semen was transferred to an Eppendorf 
tube containing one drop of 10% nigrosine and one drop 
of 1% eosin then the sperm viability test was done by the 
method as described in the WHO Laboratory Manual[24]. 
Sperm morphology was observed adopting Papanicolaou 
staining. The staining solutions were prepared according 
to the method of Raphael[25]. Sperm counts were made 
according to the method described by Gopalakrishnan[26].
2.6. Biochemical estimations
2.6.1. Estimation of cholesterol content 
  Testis tissue was carefully homogenized in Potter Elvehjem 
homogenizer using chloroform: ethanol mixture (2:1) and 
non-polar part was extracted out. The optical density was 
determined in spectrophotometer at 620 nm against blank 
(chloroform) and total cholesterol content was estimated 
according to the method of Sperry and Webb[27]. 
2.6.2. Estimation of ascorbic acid content 
  Testis tissue was homogenized in Potter Elvehjem 
homogenizer using 45 毺L ice cold 5% meta-phosphoric 
acid and centrifuged for 20 min at 3 500 g. Then, 30 毺L
supernatant, 15 毺L acetate buffer, and 15 毺L of 2, 
6-dichlorophenol-indophenol sodium (0.1 mg/mL) were 
mixed and optical density was measured against blank 
(distilled water) at 520 nm. Standard curve was drawn against 
known concentrations of ascorbic acid content[28].
2.6.3. Estimation of Δ5-3毬-hydroxysteroid dehydrogenase 
(Δ5-3毬-HSD) 
  Testis were homogenized in 0.1 M phosphate buffer 
(pH 7.4) and centrifuged at 10 000 g for 10 min at 0 曟. 
Nicotinamide adenine dinucleotide (0.2 mL) and 0.1 mL of 
dihydroxyepiandrosterone were added to supernatant and 
mixed well. This solution was kept in shaking incubator at 
35℃ for 90 min, acidified with 0.1 mL 3 M acetate buffer 
(pH 5.0) and extracted with 10 mL of ethyl acetate and 
evaporated. Residue was dissolved in 2 mL of ethanol and 
optical density was measured at 240 nm against blank 
(ethanol). The activity was estimated by the method of Rabin 
et al[29]. The protein content of tissue was determined and 
specific activity was expressed per mg of protein.
2.6.4. Estimation of glucose-6-phosphate dehydrogenase 
(G-6-PDH) 
  Testis were homogenized and centrifuged at 1 000 g (5 min) 
and 10 000×g (10 min) at 0 ℃. Tris-HCl buffer (0.025 mL; 
pH 8.3; 0.5 M), 0.01 mL of 20 mM of nicotinamide adenine 
dinucleotide phosphate, 0.02 mL of supernatant, and 0.025 mL
of glass distilled water was added and mixed well and 
optical density was measured at 340 nm against blank 
(distilled water). The activity of G-6-PDH was estimated by 
the method of Lohr and Waller[30].
  Protein was estimated with Folin’s phenol reagent and 
the activities of enzymes were expressed in unit per mg of 
protein as described by Lowry et al[31]. Fructose content 
in seminal vesicle was measured as described in WHO 
Laboratory Manual[32]. 
2.7. Statistical analysis
  Results are expressed as mean±SEM. Data obtained were 
statistically analysed by using Graphpad Prism, version 4.03 
for Windows (Graph Pad Software, San Diego, California, 
USA). Results were compared using one-factor analysis 
of variance (ANOVA) with Dunnett’s post-hoc test. Values 
were considered significant at P<0.05 or less. In many cases 
results were calculated as percentage of relevant control 
values to make understanding of the results easier.
3. Results
3.1. Acute oral toxicity
  The LD50 Cut off value was found to be 3 750 and 2 500 mg/kg
body weight for ethanolic (70%v/v) extracts of E. axillare 
leaves and U. lobata root, respectively.
3.2. Body weight and the weight of reproductive organs 
  When compared with vehicle control group, there were 
no significant differences in initial and final body weights 
between rats treated with E. axillare leaves and U. lobata 
root at both tested doses (Table 1). On the other hand, the 
weight of the testes, epididymides, seminal vesicle, ventral 
prostate and vas deferens however, were found to be 
significantly (P<0.05) decreased in treated male rats when 
compared with the weights of the same organs obtained 
from control rats (Table 2). However, these organs weights 
recovered gradually to control levels by 55 days after 
cessation of treatment (data not shown).
3.3. Effects on sperm morphology and viability
  Results recorded in Table 3 showed that percentages 
of living sperms decreased significantly in rats treated 
with the E. axillare leaves  (74.7% by low dose and 66.3% 
by high dose) and U. lobata root (62.5% by low dose and 
43.8% by high dose) when compared with vehicle control 
(92.0%). At the same time, in the vehicle control fed rats, 
90.6% of spermatozoa possess normal morphology whereas,
E. axillare leaves extract-treated rats showed about 76.6% 
and 73.4% of normal sperm morphology at the doses of 375 
and 750 mg/kg body weight, respectively, and U. lobata root 
extract-treated rats showed the corresponding percentage 
about 72.8% and 46.3% at the doses of 300 and 600 mg/kg 
body weight, respectively (Table 3). The remaining sperms 
showed abnormalities of different types. 
3.4. Effect on sperm count and sperm motility
  Cauda epididymal sperm count was decreased significantly 
after the treatment with E. axillare leaves and U. lobata root 
extracts for 55 days in comparison to the control group. Further, 
rats treated with U. lobata root at high dose (600 mg/kg
body weight) showed more reduction in sperm count and 
motility than E. axillare leaves treated rats when compared 
with vehicle control group (Tables 3 and 4). 
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3.5. Effect on epididymal protein and fructose content in the 
seminal vesicle
  The E. axillare leaves and U. lobata root at two different 
doses decreased the seminal vesicular fructose content by 
12.24% & 22.44% and 14.28% & 24.48%, respectively, when 
compared to vehicle control group (Table 4). In case of 
epididymal protein content, the U. lobata root at the doses 
of 300 and 600 mg/kg body weight showed more of reduction 
(10.60% and 14.46%, respectively) than E. axillare leaves 
(6.00% by low dose and 8.82% by high dose) when compared 
with vehicle control group. However, levels of seminal 
vesicular fructose and epididymal protein in the rats were 
recovered gradually to control levels by 55 days after 
cessation of treatment (Table 4).
3.6. Effect on testicular cholesterol, ascorbic acid and protein 
content
  When compared to vehicle control group, significantly 
(P<0.05) a dose-dependent elevation of cholesterol and 
ascorbic acid contents were noted in rats treated with 
both the plants (Table 5). Moreover, U. lobata root at high 
dose (600 mg/kg body weight) showed more elevation of 
cholesterol and ascorbic acid content by 32.99% and 34.33%, 
respectively, than E. axillare leaves (21.83% and 16.50%, 
respectively, at high dose) when compared with vehicle 
control group (Table 5). At the same time, treatment with 
both the plants resulted in reduction of protein content 
of testis. This reduction was more significant (P<0.01) in
U. lobata root (19.22% by low dose and 24.08% by high dose) 
treated rats than E. axillare leaves-treated groups (9.07% 
Table 1
Effect of ethanolic extracts of E. axillare leaves and U. lobata root on body weight of rats after 55 days of treatment (Mean依SEM, n=5).
Treatment design Dose (mg/kg body weight)
Body weight
Initial weight(g)  Weight after treatment (g) % increase in weight
Group 1 (Normal)   10 mL 181.16依4.63 236.43依6.64  30.50
Group 2 (Vehicle)   10 mL 180.43依3.27 234.47依8.53   29.95
Group 3 (EEEA) 375 mg 182.54依6.17 236.83依4.44     29.74 ns
Group 4 (EEEA) 750 mg 180.26依3.28 233.62依6.41     29.60 ns
Group 5 (EEUL) 300 mg 181.14依4.63 232.65依3.47     28.43 ns
Group 6 (EEUL) 600 mg 183.17依2.78 236.45依4.62     29.08 ns
ns= Non-significantly different from vehicle control.
EEEA and EEUL= ethanolic extracts of E. axillare leaves and U. lobata root, respectively. 
Table 2
Data on the weight of reproductive organs of male rats after treated with ethanolic extracts of E. axillare leaves and U. lobata root (Mean依SEM, n=5).
Treatment design
Dose
(mg/kg body weight)
Weight of reproductive organs
Testis 
(g)
Caput epidimidis 
(mg)
Cauda epidimidis
 (mg)
Seminal vesicles
 (mg)
Ventral prostate 
(mg)
Group 1 (Normal)   10 mL 2.81依0.08 348.86依5.74 237.46依7.76 286.52依15.66 135.14依3.16
Group 2 (Vehicle)   10 mL 2.82依0.07 347.65依8.76 235.63依8.46 287.46依13.57 134.11依4.23
Group 3 (EEEA) 375 mg
 2.62依0.04*
(-7.09)
 328.46依2.73* 
(-5.51)
 215.56依3.48*
(-8.51)
263.24依4.37*
(-8.42)
121.32依2.14
*(-9.53)
Group 4 (EEEA) 750 mg
 2.43依0.03**
(-13.82)
 311.36依3.64**
(-10.43)
   202.42依2.53**
(-14.09)
252.17依2.46**
(-12.27)
115.36依1.86**
(-13.98)
Group 5 (EEUL) 300 mg
 2.40依0.01**
(-14.87)
 323.57依1.44**
(-6.92)
214.26依4.31
*(-9.06)
259.34依1.48*
(-9.78)
120.22依1.67*
(-10.35)
Group 6 (EEUL) 600 mg
 2.24依0.06**
(-20.56)
 316.41依2.32**
(-8.98)
  196.34依3.76**
(-16.67)
247.22依2.42**
(-13.99)
108.14依2.36**
(-19.36)
*P<0.05, **P<0.01 significantly different from vehicle control. 
EEEA and EEUL= ethanolic extracts of E. axillare leaves and U. lobata root, respectively.
Table 3
Effect of ethanolic extracts of E. axillare leaves and U. lobata root on perm viability, morphology and sperm count after 55 days of treatment and 
after 56-110 days of treatment withdrawal  (Mean依SEM, n=5).
Treatment design
Dose (mg/kg 
body weight)
Sperm viability (%)
Sperm morphology
Sperm count (×106sperm/mL)
Normal sperm (%) Abnormal sperm (%)
After treatment Recovery After treatment Recovery After treatment Recovery After treatment Recovery
Group 1 (Normal)   10 mL 89.4依1.6 90.2依1.3 91.3依2.7 91.4依2.3  8.7依1.6   8.2依1.7 65.4依2.3 66.3依1.2
Group 2 (Vehicle)   10 mL 88.2依1.4 89.3依1.5 90.6依3.2 92.3依1.2  9.3依1.4   7.6依2.4 64.8依3.6 66.7依2.4
Group 3 (EEEA) 375 mg   74.7依2.1** 89.2依0.4  76.6依1.4* 91.2依1.3 21.3依1.8*   9.2依1.3    53.2依1.4**  64.5依1.7 
Group 4 (EEEA) 750 mg   66.3依1.5** 87.6依1.6   73.4依2.6** 89.3依2.4  31.1依3.3** 10.1依1.7    46.6依2.5**  62.8依2.3 
Group 5 (EEUL) 300 mg  62.5依2.2** 86.4依0.8   72.8依4.3** 88.4依1.6  36.6依2.4**   9.0依1.6    52.7依2.6**  63.4依2.8 
Group 6 (EEUL) 600 mg  43.8依1.6** 83.7依1.2   46.3依2.4** 87.5依2.2  63.2依1.8** 10.3依0.4    43.2依2.4**  61.7依3.2 
*P<0.05, **P<0.01 significantly different from vehicle control. 
EEEA and EEUL= ethanolic extracts of E. axillare leaves and U. lobata root, respectively.
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by low dose and 17.02% by high dose) as compared to that of 
vehicle control (Table 5). However, by 55 days of treatment 
withdrawal, the values recovered to control levels (Table 5).
3.7. Effect on G-6-PDH and ∆5-3毬-HSD activities
  The extracts of both the plants were found to exhibit a 
dose dependent decrease in testicular G-6-PDH activity 
when compared with control. After 55 days of treatment, 
the percent inhibition of G-6-PDH activity at two different 
doses was 6.35% and 18.49% for E. axillare leaves (375 and 
750 mg/kg body weight) and 16.42% and 34.74% for U. lobata 
root (300 and 600 mg/kg body weight), respectively (Table 
6). Similarly, the E. axillare leaves and U. lobata root at two 
different doses inhibited the testicular ∆5-3毬-HSD activity 
by 18.74% & 24.66% and 21.76% & 33.01%, respectively, 
when compared to vehicle control group. However, by 55 
days of treatment withdrawal, the values recovered to control 
levels (Table 6).
Table 4
Effect of ethanolic extracts of E. axillare leaves and U. lobata root on motility and type of movement of sperm, epididymal protein and content of 
fructose in seminal vesicular fructose content after 55 days of treatment and after 56-110 days of treatment withdrawal (Mean依SEM, n=5).
Treatment design
Types of motility Duration of motility (min)
Fructose in seminal vesicle 
(mg/g)
Protein in epididymis 
(mg/g)
After treatment Recovery After treatment Recovery After treatment Recovery After treatment Recovery
Group 1 (Normal, 10 mL/kg body 
weight)
Rapid progressive Rapid progressive 105依2 104依3 4.80依0.23 4.80依0.02 218.53依4.67 216.43依2.12
Group 2 (Vehicle, 10 mL/kg body 
weight)
Rapid progressive Rapid progressive 103依3 103依5 4.90依0.22 4.80依0.04 215.38依5.86 214.14依3.35
Group 3 (EEEA 375 mg/kg body 
weight)
Mild progressive Rapid progressive   78依4* 100依3 
4.30依0.13*
(-12.24)
4.80依0.03
202.45依3.16*
(-6.0)
212.45依2.24
Group 4 (EEEA 750 mg/kg body 
weight)
Sluggish Progressive   56依3**   99依4 
3.80依0.14**
(-22.44)
4.70依0.14
196.37依2.64**
(-8.82)
214.12依0.76
Group 5 (EEUL 300 mg/kg body 
weight)
Mild progressive Progressive   62依3** 101依2 
4.20依0.12**
(-14.28)
4.80依0.01
192.54依1.35**
(-10.60)
211.63依1.17
Group 6 (EEUL 600 mg/kg body 
weight)
Sluggish Progressive   45依2**   99依3 
3.70依0.13**
(-24.48)
4.70依0.06 
184.23依1.85**
(-14.46)
210.56依4.32
*P<0.05, **P<0.01 significantly different from vehicle control. 
EEEA and EEUL= ethanolic extracts of E. axillare leaves and U. lobata root, respectively.
 
Table 5 
Effect of ethanolic extracts of E. axillare leaves and U. lobata root on testicular cholesterol, ascorbic acid and protein content in rats after 55 days 
of treatment and after 56-110 days of treatment withdrawal (Mean依SEM, n=5).
Treatment design
Cholesterol(毺g/mg of tissue) Ascorbic acid(毺g/mg of tissue) Protein(mg/g of tissue)
After treatment Recovery After treatment Recovery After treatment Recovery
Group 1 (Normal, 10 mL/kg body weight) 87.26依2.34 88. 60依1.26 138.61依2.17 139.42依1.24 186.30依2.40 191.50依1.40
Group 2 (Vehicle, 10 mL/kg body weight) 88.43依2.42  89.12依1.38 137.83依1.36 138.34依1.53 188.50依1.70 190.60依1.80
Group 3 (EEEA 375 mg/kg body weight)
 98.81依1.34*
(+11.73)
 87.35依1.14
148.85依2.64*
(+7.99)
136.42依0.48 
171.40依1.20**
(-9.07)
188.80依0.60
Group 4 (EEEA 750 mg/kg body weight)
107.74依2.82**
(+21.83)
 87.74依1.32
160.58依1.21**
(+16.50)
137.12依0.14 
156.4 0依 2.30**
(-17.02)
188.60依0.30
Group 5 (EEUL 300 mg/kg body weight)
106.23依1.16**
(+20.12)
 87.56依1.48
167.44依2.28**
(+21.48)
136.86依1.32 
152.20依1.40**
(-19.22)
188.90依0.50
Group 6 (EEUL 600 mg/kg body weight)
117.61依2.23**
(+32.99)
 87.47依0.43
185.16依2.24**
(+34.33)
136.54依0.36 
143.10依1.60**
(-24.08)
187.70依0.20
*P<0.05, **P<0.01 significantly different from vehicle control. 
EEEA and EEUL= ethanolic extracts of E. axillare leaves and U. lobata root, respectively. 
 
Table 6
Effect of ethanolic extracts of E. axillare leaves and U. lobata root on activities of ∆5-3毬-HSD and G-6-PDH in testis of rats after 55 days of 
treatment and after 56-110 days of treatment withdrawal (Mean依SEM, n=5).
Treatment design
Specific activity of ∆5-3毬-HSD(U /mg of protein) Specific activity of G-6-PDH(U /mg of protein)
After treatment Recovery After treatment Recovery
Group 1 (Normal, 10 mL/kg body weight) 8.52依0.06 7.68依0.26 23.22依0.34 23.47依0.16
Group 2 (Vehicle, 10 mL/kg body weight) 8.27依0.12 7.52依0.15 23.14依0.12 23.82依0.31
Group 3 (EEEA 375 mg/kg body weight) 6.72依0.37*(-18.74) 7.36依0.54 21.67依0.54**(-6.35) 23.41依0.04 
6.23依0.26**(-24.66) 7.12依0.14 18.86依0.32**(-18.49) 23.17依0.30 
Group 5 (EEUL 300 mg/kg body weight) 6.47依0.24**(-21.76) 7.44依 0.36 19.34依0.33**(-16.42) 23.26依0.13 
Group 6 (EEUL 600 mg/kg body weight) 5.54依0.31**(-33.01) 7.41依0.13 15.10依0.24**(-34.74) 23.11依0.14 
*P<0.05, **P<0.01 significantly different from vehicle control. 
EEEA and EEUL= ethanolic extracts of E. axillare leaves and U. lobata root, respectively.
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4. Discussion 
  In the present investigation, 10% and 20% of the LD50 cut-
off value were selected as doses of ethanolic extracts of
E. axillare leaves or U. lobata root. In our study, the 
results indicated that the body weights of rats treated with
E. axillare leaves or U. lobata root evan at high dose 
suggesting that the these plants have no side effect or 
toxicological effect and maintained normal physiology of the 
animals throughout the experiment.
  It is well known that the male accessory reproductive 
organs play an important role in the sperm maturation, 
motility and formation of semen[32]. In the present 
investigation, treatment with E. axillare leaves or U. lobata 
root for 55 days resulted in a decrease in weights of testis 
and cauda epididymis after 55 days of treatment, which 
could be attributed to a decline in epididymal sperm 
count and sperm motility inhibition with reduced viability 
and increased sperm abnormality since the inadequate 
concentration, sluggishly motile or immotile spermatozoa 
could not penetrate the cervical mucus and thus failed to 
fertilize the ova[33, 34].  Moreover, in our study, a low fructose 
concentration and a reduction in seminal vesicle weight of 
rats treated with high doses of E. axillare leaves or U. lobata 
root would be another cause of reduction in sperm motility 
since motile sperm consumes fructose after ejaculation[35].
  The present study reveals the reduction in the level of 
protein of testes and epididymis, which might be a causative 
factor in reducing the weight of reproductive organs, because 
the growth rate of organ is proportional to its protein content, 
and may also be another reason for declined sperm count 
and motility[36-38]. This idea was further strengthened by 
the accumulation of testicular cholesterol and ascorbic acid 
contents in rats treated with E. axillare leaves or U. lobata 
root for 55 days since these substrates, cholesterol and 
ascorbic acid are the principal precursors for the formation 
of androgens in biogenic pathway in the testis[39-41].
  The depressed testicular steroidogenic activity and 
hypofunctioning of the glands was further evident by the 
diminished values of testicular ∆5-3毬-HSD and G-6-PDH 
dehydrogenase activities after treated with both doses of 
E. axillare leaves or U. lobata root suggesting both plants 
might prevent cholesterol conversion into testosterone by 
impairing activities of these two key regulatory enzymes 
involved in androgen biogenesis[37,42]. 
  However, after withdrawal of the extract for a period of 
55 days, the weight of reproductive organs, sperm count, 
motility, viability, morphology, testicular biochemicals and 
enzymes of the extract-treated male rats were similar to 
those of the vehicle-treated control group, which suggested 
that the impacts of E. axillare leaves and U. lobata root 
extracts on male reproductive functions were reversible. 
  This study suggests that the E. axillare leaves and U. lobata
roo t  revers ib ly  inh ib i ted  spermatogenes i s  and 
steroidogenesis indicating reversible antifertility activity 
which could partially support the traditional of these plants 
as male contraceptives. Further detailed studies should 
be carried out using different animal species to establish 
its antifertility activity, determine the active principles 
responsible and also understand underlying cellular 
mechanism of action.
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